Article
Role of genetic polymorphisms on opioid safety and efficacy in cancer pain: A systematic review and meta-analysis.
European journal of pharmacology - 28 Aug 2026
Akan Mikail, Panina Aleksandra, Khandokhin Mikhail, Mohammad Salahuddin, Schiöth Helgi B, Mwinyi Jessica
Abstract excerpt
Pain is one of the most prevalent and challenging symptoms in cancer, and opioids remain central to its management. Genetic factors are thought to underlie interindividual variability in opioid response, yet findings across pharmacogenomic studies have been inconsistent. We conducted a systematic review and seven meta-analyses across 24 independent populations (n = 4190), evaluating the three most frequently...
Topics
Join the communities discussing this publication.
